Stan Polovets is the Co-Founder and CEO of The Genesis Prize Foundation, a global not-for-profit committed to celebrating and recognizing Jewish achievement across a myriad of fields, industries, and specializations. In addition to this notable role, Stan Polovets has amassed decades worth of experience as an innovator in business. He served as CEO of the Alfa-Access-Renova (AAR) Consortium, a private equity firm with a global energy portfolio valued in excess of $25 billion. In 2020, he was elected Chairman of the Board of Anchiano Therapeutics Ltd., a NASDAQ-listed biopharmaceutical company dedicated to the discovery and development of cancer treatments. During his tenure at Anchiano, the company posted a 630% return over 12 months.
On this channel, please enjoy video content related to the Genesis Prize, Stan Polovets, and recent media coverage.